Breaking News Instant updates and real-time market news.

VCYT

Veracyte

$9.32

0.17 (1.86%)

13:24
10/07/18
10/07
13:24
10/07/18
13:24

Veracyte announces new data from multiple studies in thyroid cancer diagnosis

Veracyte announced that new findings from six studies reinforcing the "real world" performance of the next-generation Afirma Genomic Sequencing Classifier and the Afirma Xpression Atlas in thyroid cancer diagnosis were presented at the 88th Annual Meeting of the American Thyroid Association. Researchers from leading institutions presented posters showing that use of the Afirma GSC at their respective centers significantly increased the identification of benign thyroid nodules among those deemed indeterminate - not clearly benign or malignant - following cytopathology review, compared to the original Afirma test. The Ohio State University - Researchers compared results of 113 indeterminate samples that were tested with the Afirma GSC to those of 403 samples using the earlier version of the test. The Afirma GSC identified 74.1% of the nodules as benign, compared to 48.4% with the GEC, an increase of 53%. The overall surgery rate among all patients who underwent genomic testing decreased by more than half - from 42.2% with the GEC to 20.2% with the GSC. Cleveland Clinic - Comparing results of 46 samples tested with the Afirma GSC between July 2017 and December 2017 with 182 samples tested with the original test between December 2011 and July 2017, researchers found that the GSC identified 67.4% as benign, compared to 41.8% with the GEC - an increase of 61%. The overall surgery rate for nodules tested with the GSC was 32.6%, compared to 47.3% with the original test, a decrease of 31%. Brigham and Women's Hospital - Researchers evaluated results for 583 thyroid nodules tested with either the Afirma GSC or GEC between 2011 and 2018. They found that the Afirma GSC identified 64.9% of nodules as benign, compared to 47.9% with the GEC, an increase of 35%. Additionally, in two oral presentations, researchers shared the first "real world" Afirma Xpression Atlas data, providing insights into the distribution of a wide range of gene variants and fusions across key categories of indeterminate thyroid nodules and Afirma GSC results.

VCYT Veracyte
$9.32

0.17 (1.86%)

11/07/17
PIPR
11/07/17
DOWNGRADE
Target $8
PIPR
Neutral
Veracyte downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst William Quirk downgraded Veracyte to Neutral after the company missed Q3 revenue expectations and guided Q4 and 2018 well below estimates. The company, now more than ever, is a "show-me story," Quirk tells investors in a post-earnings research note. He cut his price target for the shares to $8 from $10.
11/07/17
JANY
11/07/17
DOWNGRADE
JANY
Neutral
Veracyte downgraded to Neutral from Buy at Janney Capital
11/07/17
11/07/17
DOWNGRADE
Target $9

Neutral
Veracyte downgraded to Neutral on slow Percepta traction at Janney Capital
As previously reported, Janney Capital analyst Paul Knight downgraded Veracyte to Neutral from Buy citing slower than expected traction for its new lung cancer diagnostic, Percepta, paired with lower than expected growth for its core thyroid test. Knight, who lowered his FY18 revenue estimate for Veracyte to $83M from about $100M, cut his fair value estimate on the stock to $9 from $15.
07/24/18
PIPR
07/24/18
NO CHANGE
Target $11
PIPR
Neutral
Veracyte price target raised to $11 from $7 at Piper Jaffray
Piper Jaffray analyst William Quirk raised his price target for Veracyte to $11 following the company's Q2 sales beat and increased 2018 guidance. Veracyte is entering a "new multi-faceted growth cycle" and deserves a premium multiple, Quirk tells investors in a post-earnings research note. The analyst keeps a Neutral rating on the shares but has a "positive bias." He views the new guidance as "not only achievable but potentially beatable."

TODAY'S FREE FLY STORIES

REV

Revlon

$24.60

-0.09 (-0.36%)

10:06
10/23/18
10/23
10:06
10/23/18
10:06
Periodicals
Mox Reports repeats long call on Revlon »

MoxReports tweeted:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNT

Fortinet

$81.75

-1.22 (-1.47%)

10:05
10/23/18
10/23
10:05
10/23/18
10:05
Hot Stocks
Fortinet paid $18M in initial consideration for ZoneFox »

As previously reported,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 10

    Dec

SIEGY

Siemens

$0.00

(0.00%)

10:05
10/23/18
10/23
10:05
10/23/18
10:05
Periodicals
Siemens delays signing $20B Saudi power deal, Bloomberg reports »

The decision by Siemens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$25.48

-0.63 (-2.41%)

10:03
10/23/18
10/23
10:03
10/23/18
10:03
Hot Stocks
MGM Resorts names Adam Greenblatt as CEO of MGM GVC Interactive JV »

MGM GVC Interactive LLC,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

10:02
10/23/18
10/23
10:02
10/23/18
10:02
General news
Richmond Fed Manufacturing Index Level data reported »

October Richmond Fed…

FTNT

Fortinet

$81.31

-1.66 (-2.00%)

, PANW

Palo Alto Networks

$192.00

-2.25 (-1.16%)

10:01
10/23/18
10/23
10:01
10/23/18
10:01
Recommendations
Fortinet, Palo Alto Networks analyst commentary  »

Fortinet deal makes…

FTNT

Fortinet

$81.31

-1.66 (-2.00%)

PANW

Palo Alto Networks

$192.00

-2.25 (-1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 10

    Dec

THFF

First Financial

$45.99

-0.93 (-1.98%)

10:01
10/23/18
10/23
10:01
10/23/18
10:01
Earnings
First Financial reports Q3 EPS 92c, consensus 89c »

Book value per share was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$40.13

-1.5 (-3.60%)

10:00
10/23/18
10/23
10:00
10/23/18
10:00
Options
Call buyers in Canopy Growth weeklies as shares extend losses »

Call buyers in Canopy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

DWT

Britannia Bulk

$6.41

0.44 (7.37%)

10:00
10/23/18
10/23
10:00
10/23/18
10:00
Hot Stocks
Britannia Bulk rises 7.4% »

Britannia Bulk is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$59.76

6.42 (12.04%)

10:00
10/23/18
10/23
10:00
10/23/18
10:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF rises 11.7% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABG

Asbury Automotive

$66.90

7.29 (12.23%)

10:00
10/23/18
10/23
10:00
10/23/18
10:00
Hot Stocks
Asbury Automotive rises 13.4% »

Asbury Automotive is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

FTNT

Fortinet

$80.47

-2.5 (-3.01%)

09:55
10/23/18
10/23
09:55
10/23/18
09:55
Hot Stocks
Fortinet acquires cloud-based threat analytics company ZoneFox »

Fortinet announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 10

    Dec

HAL

Halliburton

$34.80

-1.56 (-4.29%)

09:55
10/23/18
10/23
09:55
10/23/18
09:55
Options
Halliburton put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$171.99

5.46 (3.28%)

, PHM

PulteGroup

$21.37

0.49 (2.35%)

09:55
10/23/18
10/23
09:55
10/23/18
09:55
Options
Early notable gainers among liquid option names on October 23rd »

Notable gainers among…

MCD

McDonald's

$171.99

5.46 (3.28%)

PHM

PulteGroup

$21.37

0.49 (2.35%)

VZ

Verizon

$56.43

1.47 (2.67%)

ZION

Zions Bancorp

$46.36

1.025 (2.26%)

BIIB

Biogen

$324.52

8.85 (2.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 12

    Nov

  • 13

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$271.45

-3.57 (-1.30%)

09:52
10/23/18
10/23
09:52
10/23/18
09:52
Technical Analysis
Technical Take: SPDR S&P 500 ETF hits lows of October 11, bull pattern potential »

There may be an attempt…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$271.45

-3.57 (-1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$61.79

-0.065 (-0.11%)

09:51
10/23/18
10/23
09:51
10/23/18
09:51
Initiation
Tyson Foods initiated  »

Tyson Foods initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 03

    Mar

TAP

Molson Coors

$58.09

-0.79 (-1.34%)

09:51
10/23/18
10/23
09:51
10/23/18
09:51
Initiation
Molson Coors initiated  »

Molson Coors initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

URI

United Rentals

$109.59

-5.31 (-4.62%)

09:50
10/23/18
10/23
09:50
10/23/18
09:50
Initiation
United Rentals initiated  »

United Rentals initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBI

Hanesbrands

$16.39

-0.19 (-1.15%)

09:50
10/23/18
10/23
09:50
10/23/18
09:50
Initiation
Hanesbrands initiated  »

Hanesbrands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:50
10/23/18
10/23
09:50
10/23/18
09:50
Hot Stocks
Breaking Hot Stocks news story  »

Bio Rad Laboratories…

LASR

nLight

$18.00

-0.6 (-3.23%)

09:48
10/23/18
10/23
09:48
10/23/18
09:48
Recommendations
nLight analyst commentary  »

nLight price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

ACB

Aurora Cannabis

$7.61

(0.00%)

09:47
10/23/18
10/23
09:47
10/23/18
09:47
Hot Stocks
Aurora Cannabis falls -12.5% »

Aurora Cannabis is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATI

Allegheny Technologies

$22.90

-3.92 (-14.62%)

09:47
10/23/18
10/23
09:47
10/23/18
09:47
Hot Stocks
Allegheny Technologies falls -13.7% »

Allegheny Technologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

EDU

New Oriental Education

$54.97

-7.78 (-12.40%)

09:47
10/23/18
10/23
09:47
10/23/18
09:47
Hot Stocks
New Oriental Education falls -13.5% »

New Oriental Education is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 01

    Nov

  • 02

    Nov

LABD

Daily S&P Biotech Bear 3x Shares

$37.44

2.23 (6.33%)

09:47
10/23/18
10/23
09:47
10/23/18
09:47
Hot Stocks
Daily S&P Biotech Bear 3x Shares rises 6.8% »

Daily S&P Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.